ARRAY BIOPHARMA INC Insider Trading for April 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARRAY BIOPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARRAY BIOPHARMA INC for April 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 0.00 | 18,906 | 0 | 56,719 | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Payment of Exercise | F | 8.94 | 12,042 | 107,655 | 114,327 | 126.4 K to 114.3 K (-9.53 %) |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 0.00 | 18,906 | 0 | 126,369 | 107.5 K to 126.4 K (+17.59 %) |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 7,812 | 0 | 23,438 | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Payment of Exercise | F | 8.94 | 5,022 | 44,897 | 172,406 | 177.4 K to 172.4 K (-2.83 %) |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 0.00 | 7,812 | 0 | 177,428 | 169.6 K to 177.4 K (+4.61 %) |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | M | 0.00 | 6,875 | 0 | 20,625 | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Payment of Exercise | F | 8.94 | 4,535 | 40,543 | 37,526 | 42.1 K to 37.5 K (-10.78 %) |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Buy | M | 0.00 | 6,875 | 0 | 42,061 | 35.2 K to 42.1 K (+19.54 %) |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 0.00 | 9,843 | 0 | 29,532 | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Payment of Exercise | F | 8.94 | 6,293 | 56,259 | 39,558 | 45.9 K to 39.6 K (-13.72 %) |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Buy | M | 0.00 | 9,843 | 0 | 45,851 | 36 K to 45.9 K (+27.34 %) |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Option Exercise | M | 0.00 | 6,718 | 0 | 20,157 | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Payment of Exercise | F | 8.94 | 4,408 | 39,408 | 42,064 | 46.5 K to 42.1 K (-9.49 %) |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Buy | M | 0.00 | 6,718 | 0 | 46,472 | 39.8 K to 46.5 K (+16.90 %) |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 4.36 | 20,000 | 87,200 | 0 | ||
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 3.69 | 25,000 | 92,250 | 0 | ||
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Sell | S | 8.92 | 45,000 | 401,400 | 6,585 | 51.6 K to 6.6 K (-87.23 %) | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 4.36 | 20,000 | 87,200 | 51,585 | 31.6 K to 51.6 K (+63.32 %) | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 3.69 | 25,000 | 92,250 | 31,585 | 6.6 K to 31.6 K (+379.65 %) | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Gift | G | 0.00 | 2,000 | 0 | 6,585 | 8.6 K to 6.6 K (-23.30 %) |